Basant Agro Tech (524687)
CyclicalScore breakdown: P/E: 2/3 · ROCE: 0/2 · Growth: 2/2 · Dividend: 0/1
Key Financials
| Current Price | ₹20.68 |
| Market Cap | ₹189.17 Cr |
| P/E Ratio | 15.94 |
| ROCE | 6.52% |
| ROE | 3% |
| Dividend Yield | 0.48% |
| Profit Growth | 228.95% |
| Debt/Equity | — |
| Sales Growth | 51.65% |
| 52-Week Range | ₹9.2 — ₹20.68 |
| Sector | Fertilizers & Agrochemicals |
| Book Value | ₹19.96 |
Strengths
- P/B of 1.04 means the stock trades close to book value of ₹19.96, offering some asset support.
- Sales growth of 51.65% and profit growth of 228.95% indicate recent operational momentum.
- Piotroski F-Score of 7/9 points to improving fundamentals across profitability, leverage and efficiency.
- P/E of 15.94 is not extreme, and the stock is near the top of its 52-week range, showing market interest.
Concerns
- ROE of 3.00% and ROCE of 6.52% are far below acceptable levels for a quality compounder.
- Latest quarter net profit of ₹1 crore on sales of ₹123 crore implies very poor margin and earnings quality.
- Fertilizer industry is commoditized and dependent on government policy, subsidies and monsoon cycles.
- Promoter holding and debt/equity data are unavailable; transparency is a concern for a small-cap investment.
AI Analysis
At first glance, a 15.94 P/E, a 1.04 P/B and a 228.95% profit growth figure would make any value investor pause. But after reading through the numbers, I'm reminded of Buffett's rule: it's far better to buy a wonderful business at a fair price than a fair business at a wonderful price. Basant Agro is not a wonderful business. A 3.00% return on equity and 6.52% return on capital are far below what an owner should accept. I am essentially paying book value of ₹19.96 for a price of ₹20.68, but that book value is not compounding at a satisfactory rate. The sales growth of 51.65% looks strong, but the latest quarter tells the real story: ₹123 crore in sales produced only ₹1 crore in net profit. That is a razor-thin margin. Fertilizers are commodities, with government policy, subsidies and monsoon cycles dictating demand; there is little pricing power and no real moat. The 228.95% profit growth is mathematically impressive but comes off a tiny, cyclical base. The low PEG of 0.11 is an arithmetic artifact, not an endorsement of quality. The Piotroski F-score of 7/9 suggests recent operational improvements, and I acknowledge that, but a single good year does not make a durable franchise. Also, I cannot assess promoter commitment or true leverage because those data are missing. With a dividend yield of only 0.48%, shareholders are not being paid well to wait. I would file this under Cyclical. Only if we see sustained margin expansion, higher ROE and proof that this is not just a fertilizer upcycle will I change my mind. Until then, I will watch from the sidelines.
Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer